Format

Send to

Choose Destination
BMJ Open. 2017 May 11;7(5):e015424. doi: 10.1136/bmjopen-2016-015424.

Estimating the prevalence, hospitalisation and mortality from type 2 diabetes mellitus in Nigeria: a systematic review and meta-analysis.

Author information

1
Demography and Social Statistics, Covenant University, Ota, Nigeria.
2
Centre for Global Health Research, Usher Institute, University of Edinburgh, Edinburgh, UK.
3
Faculty of Health and Applied Sciences, University of the West of England, Bristol, UK.
4
Department of Biochemistry, College of Health Sciences, Osun State University, Osogbo, Nigeria.
5
Economics and Development Studies, Covenant University, Ota, Nigeria.
6
School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston, UK.

Abstract

BACKGROUND:

There is not yet a comprehensive evidence-based epidemiological report on type 2 diabetes mellitus (T2DM) in Nigeria. We aimed to estimate country-wide and zonal prevalence, hospitalisation and mortality rates of T2DM in Nigeria.

METHODS:

We searched MEDLINE, EMBASE, Global Health, Africa Journals Online (AJOL) and Google Scholar for population and hospital-based studies on T2DM in Nigeria. We conducted a random-effects meta-analysis on extracted crude estimates, and applied a meta-regression epidemiological model, using the United Nations demographics for Nigeria in 1990 and 2015 to determine estimates of diabetes in Nigeria for the two years.

RESULTS:

42 studies, with a total population of 91 320, met our selection criteria. Most of the studies selected were of medium quality (90.5%). The age-adjusted prevalence rates of T2DM in Nigeria among persons aged 20-79 years increased from 2.0% (95% CI 1.9% to 2.1%) in 1990 to 5.7% (95% CI 5.5% to 5.8%) in 2015, accounting for over 874 000 and 4.7 million cases, respectively. The pooled prevalence rate of impaired glucose tolerance was 10.0% (95% CI 4.5% to 15.6%), while impaired fasting glucose was 5.8% (95% CI 3.8% to 7.8%). Hospital admission rate for T2DM was 222.6 (95% CI 133.1 to 312.1) per 100 000 population with hyperglycaemic emergencies, diabetic foot and cardiovascular diseases being most common complications. The overall mortality rate was 30.2 (95% CI 14.6 to 45.8) per 100 000 population, with a case fatality rate of 22.0% (95% CI 8.0% to 36.0%).

CONCLUSION:

Our findings suggest an increasing burden of T2DM in Nigeria with many persons currently undiagnosed, and few known cases on treatment.

KEYWORDS:

Nigeria; complications; diabetes; epidemiology; mortality; prevalence

PMID:
28495817
PMCID:
PMC5566593
DOI:
10.1136/bmjopen-2016-015424
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center